Korea Pharmaceutical Manufacturers Association welcomed the decision to abolish market based actual transaction price

On Feb 14, Korea Pharmaceutical Manufacturers Association announced that they welcome the decision of consultative group for improving drug insurance system, because the group decided to abolish market based actual transaction price and replace with a normal, rational alternative plan.

Korea Pharmaceutical Manufacturers Association said that they judge this decision as exemplary case that impl...